Continuation of therapeutic dose heparin for critically ill patients with COVID-19.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Charlotte A. Bradbury, Patrick R. Lawler, Bryan J. McVerry & Ryan Zarychanski on behalf of the REMAP-C. A. P. Investigators

Journal title: Intensive care medicine

Journal publisher: Springer Science+Business Media

Published year: 2023

DOI identifier: 10.1007/s00134-023-07095-8

ISSN: 1432-1238